Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 09:27 am Purchase | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | Deep Track Capital, LP | 3,282,000 3.270% | 1,282,000 (+64.10%) | Filing History |
| 2024-11-14 09:24 am Sale | 2024-09-30 | 13G | AnaptysBio, Inc. ANAB | Deep Track Capital, LP | 0 0.000% | -2,036,990 (Position Closed) | Filing History |
| 2024-11-14 09:21 am Sale | 2024-09-30 | 13G | Agenus Inc. AGEN | Deep Track Capital, LP | 0 0.000% | -1,584,877 (Position Closed) | Filing History |
| 2024-11-14 09:20 am Purchase | 2024-09-30 | 13G | Olema Pharmaceuticals, Inc. OLMA | Deep Track Capital, LP | 4,000,000 6.980% | 959,752 (+31.57%) | Filing History |
| 2024-11-14 09:18 am Sale | 2024-09-30 | 13G | Nektar Therapeutics NKTR | Deep Track Capital, LP | 15,922,655 8.650% | -2,477,345 (-13.46%) | Filing History |
| 2024-11-14 09:17 am Purchase | 2024-09-30 | 13G | Korro Bio, Inc. KRRO | Deep Track Capital, LP | 850,000 9.140% | 135,715 (+19.00%) | Filing History |
| 2024-11-14 09:16 am Purchase | 2024-09-30 | 13G | Invivyd, Inc. IVVD | Deep Track Capital, LP | 10,953,937 9.170% | 1,953,937 (+21.71%) | Filing History |
| 2024-11-14 09:13 am Purchase | 2024-09-30 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Deep Track Capital, LP | 4,096,452 7.880% | 1,812,080 (+79.33%) | Filing History |
| 2024-11-14 09:12 am Purchase | 2024-09-30 | 13G | Autolus Therapeutics plc AUTL | Deep Track Capital, LP | 15,272,172 5.740% | 3,402,875 (+28.67%) | Filing History |
| 2024-11-14 09:09 am Sale | 2024-09-30 | 13G | ABIVAX SA ABVX | Deep Track Capital, LP | 3,579,209 5.080% | -718,229 (-16.71%) | Filing History |
| 2024-10-24 4:06 pm Purchase | 2024-10-22 | 13D | Dynavax Technologies Corporation DVAX | Deep Track Capital, LP | 17,791,486 13.600% | 5,265,000 (+42.03%) | Filing History |
| 2024-10-23 4:15 pm Sale | 2024-10-22 | 13G | OnKure Therapeutics, Inc. OKUR | Deep Track Capital, LP | 660,136 5.220% | -24,020 (-3.51%) | Filing History |
| 2024-10-11 4:00 pm Purchase | 2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR | Deep Track Capital, LP | 684,156 5.410% | 684,156 (New Position) | Filing History |
| 2024-10-07 4:17 pm Purchase | 2024-10-02 | 13G | Guardant Health, Inc. GH | Deep Track Capital, LP | 6,580,257 5.350% | 579,697 (+9.66%) | Filing History |
| 2024-10-07 4:00 pm Sale | 2024-09-30 | 13G | Guardant Health, Inc. GH | Deep Track Capital, LP | 6,000,560 4.880% | -999,440 (-14.28%) | Filing History |
| 2024-09-23 4:00 pm Purchase | 2024-09-13 | 13G | MBX Biosciences, Inc. Common Stock MBX | Deep Track Capital, LP | 3,018,935 9.480% | 3,018,935 (New Position) | Filing History |
| 2024-09-16 4:05 pm Purchase | 2024-09-16 | 13D | Dynavax Technologies Corporation DVAX | Deep Track Capital, LP | 12,526,486 9.560% | 5,433,272 (+76.60%) | Filing History |
| 2024-07-12 4:04 pm Purchase | 2024-07-03 | 13G | Verona Pharma plc VRNA | Deep Track Capital, LP | 32,932,392 5.080% | 32,932,392 (New Position) | Filing History |
| 2024-07-02 4:01 pm Purchase | 2024-06-27 | 13G | Climb Bio, Inc. CLYM | Deep Track Capital, LP | 3,904,785 5.850% | 3,904,785 (New Position) | Filing History |
| 2024-05-10 4:00 pm Purchase | 2024-05-02 | 13G | Context Therapeutics Inc. CNTX | Deep Track Capital, LP | 7,419,355 9.890% | 7,419,355 (New Position) | Filing History |